Protalix BioTherapeutics Inc (AMEX:PLX) currently has a daily average trading volume of 1.12M but it saw 409479 shares traded in last market. With a market cap of 122.59M USD, the company’s current market price of $1.54 came rising about 2.67 while comparing to the previous closing price of $1.5. In past 52 weeks, the stock remained buoying in the range of price level as high as $3.10 and as low as $0.82.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which reiterated the stock as “Buy” in its note to investors issued on June 08, 2020, recommending a price target of between $3 and $11 for it. Rodman & Renshaw issued its recommendations for the stock as it initiated the price target for the stock is $3.50.
Over the week, PLX’s stock price is moving 6.21% up while it is -3.75% when we observe its performance for the past one month. Year-to-date it is 31.62% up and over the past year, the stock is showing a downside performance of -18.09%.
Currently, Protalix BioTherapeutics Inc’s total number of outstanding shares is 78.13M. Company’s return on investment (ROI) stands at 7.97% and return on equity (ROE) at 10.42%. It has a price to earnings ratio (P/E ratio) of 36.67 while having a 3.42 of forward P/E ratio. Stock’s beta reads -0.21. Stock has a price to book (P/B) ratio of 2.66 while price to sale or P/S ratio amounts to 2.05. Its return on asset (ROA) is 4.77% on average.
